Patents by Inventor Qingyi ZHOU

Qingyi ZHOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240102955
    Abstract: A non-invasive time domain reflection probe calibration method includes: using different volume ratio of ethanol and deionized water mixed solution to calculate a test target's medium weight coefficient and waveguide length of the non-invasive time domain reflection probes; using different concentrations of NaCl solutions to calibrate a waveguide geometric dimensioning of the non-invasive time domain reflection probes; preparing compacted soil samples with known different moisture contents and densities, and calibrating a correlation parameter of compacted soil samples' dielectric constant and conductivity with moisture content and density. The method not only determines the sensitivity of the test target medium of the non-invasive time domain reflection probes, but also obtains the waveguide length and geometric dimensioning of the probe, and realizes an accurate test of moisture content and density of the soil.
    Type: Application
    Filed: July 28, 2023
    Publication date: March 28, 2024
    Applicants: China Jikan Research Institute Of Engineering Investigations And Design, Co.,Ltd, Xi'an Jiaotong University
    Inventors: Jie CAO, Yonglin YANG, Zaixin WAN, Peng GAO, Qingyi MU, Dongjing WANG, Yuanqiang ZHOU, Zhi LIU, Long ZHANG, Hui LI, Jian CHEN, Teng YANG, Lei RAN, Jiao LIN, Xiao DONG, Shuai LIU, Weiwei ZHAO
  • Publication number: 20200121706
    Abstract: A method for inhibiting myopia and an application in preparing a drug. According to the invention, myopia is inhibited by an anti-hypoxia effect achieved by inhibiting the expression of intraocular HIF-1?, and myopia is effectively delayed and inhibited by an anti-hypoxia effect achieved by inhibiting the effect of intraocular HIF-1?. The present invention utilizes HIF-1? inhibitors salidroside and formononetin to inhibit HIF-1? activity to play an anti-hypoxia effect and play a role in delaying myopia.
    Type: Application
    Filed: August 16, 2017
    Publication date: April 23, 2020
    Inventors: Jia QU, Fei ZHAO, Xiangtian ZHOU, Miaozhen PAN, Sen ZHANG, Qingyi ZHOU, Hao WU